Functional correlates of insertion mutations in the protease gene of human immunodeficiency virus type 1 isolates from patients

Journal of Virology

Volumn 75, Issue 22, 2001, Pages 11227-11233

  Kim, E Y ^a   Winters, M A ^a   Kagan, R M ^a   Merigan, T C ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID; PROTEINASE; PROTEINASE INHIBITOR;

ARTICLE; CLINICAL ARTICLE; CODON; CONTROLLED STUDY; DRUG RESISTANCE; DRUG SENSITIVITY; GENE INSERTION; GENE MAPPING; GENE MUTATION; GENOTYPE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PRIORITY JOURNAL; VIRUS GENE; VIRUS ISOLATION; VIRUS REPLICATION;

ACQUIRED IMMUNODEFICIENCY SYNDROME; GENOTYPE; HIV PROTEASE; HIV-1; HUMANS; MUTAGENESIS, INSERTIONAL; RECOMBINATION, GENETIC; VIRUS REPLICATION;

EID: 0034764066     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.75.22.11227-11233.2001     Document Type: Article

References (34)

1. Resistance to human immunodeficiency virus type I protease inhibitors
2. Dynamics of dominance of dipeptide insertion in reverse transcriptase of HIV-1 from patients subjected to prolonged therapy
3. Zidovudine resistance and HIV-1 disease progression during antiretroviral therapy
4. Fine characterization of the antigenic site within the flap region in the protease protein of HIV-1
5. Structure and function of retroviral proteases
6. HIV-1 with an insertion in protease is drug-susceptible, replication-competent and transmissible
7. Relative replicative fitness of zidovudine-resistant human immunodeficiency virus type I isolates in vitro
8. Pausing of reverse transcriptase on retroviral RNA templates is influenced by secondary structures both 5' and 3' of the catalytic site
9. Standardized peripheral blood mononuclear cell culture assay for determination of drug susceptibilities of clinical human immunodeficiency virus type I isolates
10. Construction of defined deletion mutants by thermal cycled fusion: Applications to protein kinase C
11. Anti-HIV type 1 activity of 3'-fluoro-3'-deoxythymidine for several different multidrug-resistant mutants
12. Evidence for unique mechanism of strand transfer from the transactivation response region of HIV-1
13. Comparative fitness of multi-dideoxynucleoside-resistant human immunodeficiency virus type 1 (HIV-1) in an in vitro comparative HIV-1 replication assay
14. A family of insertion mutations between codons 67 and 70 of human immunodeficiency virus type 1 reverse transcriptase confer multi-nucleoside analog resistance
15. Genotypic and phenotypic analysis of human immunodeficiency virus type 1 isolates from patients on prolonged stavudine therapy
16. Structural and kinetic analysis of drug resistance of HIV-1 protease
17. New insertion in HIV-1 protease gene associated with indinavir resistance
18. Replicative fitness of protease inhibitor-resistant mutants of human immunodeficiency virus type 1
19. Analysis of resistance to human immunodeficiency virus type 1 protease inhibitors by using matched bacterial expression and proviral infection vectors
20. The accuracy of reverse transcriptase from HIV-1
21. Domain flexibility in retroviral proteases: Structural implications for drug resistant mutations
22. Human immunodeficiency virus type 1 viral background plays a major role in development of resistance to protease inhibitors
23. Clinical cross-resistance between the HIV-1 protease inhibitors saquinavir and indinavir and correlations with genotypic mutations
24. Mutational anatomy of an HIV-1 protease variant conferring cross-resistance to protease inhibitors in clinical trials. Compensatory modulations of binding and activity
25. Human immunodeficiency virus reverse transcriptase and protease sequence database
26. Human immunodeficiency virus type 1 reverse transcriptase and protease mutation search engine for queries
27. Decreased processivity of human immunodeficiency virus type 1 reverse transcriptase (RT) containing didanosine-selected mutation Leu74Val: A comparative analysis of RT variants Leu74Val and lamivudine-selected Met184Val
28. Multidrug resistance genotypes (insertions in β3-β4 finger subdomain and MDR mutations) of HIV-1 reverse transcriptase from extensively treated patients: Incidence and association with other resistance mutations
29. A cooperative folding unit in HIV-1 protease. Implications for protein stability and occurrence of drug-induced mutations
30. Human immunodeficiency virus type I protease genotypes and in vitro protease inhibitor susceptibilities of isolates from individuals who were switched to other protease inhibitors after long-term saquinavir treatment
31. A 6-basepair insert in the reverse transcriptase gene of human immunodeficiency virus type 1 confers resistance to multiple nucleoside inhibitors
32. Human immunodeficiency virus type 1 reverse transcriptase genotype and drug susceptibility changes in infected individuals receiving dideoxyinosine monotherapy for 1 to 2 years
33. Analysis of HIV type 1 reverse transcriptase: Comparing sequences of viral isolates with mutational data
34. Strand transfer mediated by human immunodeficiency virus reverse transcriptase in vitro is promoted by pausing and results in misincorporation